Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.8 USD | +1.90% | +3.58% | +30.37% |
Mar. 20 | Aurobindo Pharma Gets US FDA Final Nod for Mometasone Furoate Monohydrate Nasal Spray | MT |
Feb. 28 | Philips: new CFO in October | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.37% | 4.72B | |
+33.46% | 701B | |
+26.24% | 571B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-3.61% | 157B |
- Stock
- Equities
- Stock Organon & Co. - Nyse
- News Organon & Co.
- Goldman Sachs Adjusts Price Target for Organon & Co to $41 From $42, Maintains Buy Rating